PI
AGN

PEAK6 Investments’s Allergan plc AGN Stock Holding History

PEAK6 Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-49,700
Closed -$8.8M – 5048
2020
Q1 		$8.8M Sell
49,700
-45,900
-48% -$8.64M 0.05% 343
2019
Q4 		$18.3M Buy
95,600
+18,100
+23% +$3.27M 0.09% 202
2019
Q3 		$13M Sell
77,500
-36,300
-32% -$5.91M 0.08% 265
2019
Q2 		$19.1M Buy
113,800
+13,500
+13% +$1.87M 0.13% 166
2019
Q1 		$14.7M Buy
100,300
+40,500
+68% +$5.87M 0.09% 245
2018
Q4 		$7.99M Buy
59,800
+8,100
+16% +$1.33M 0.05% 418
2018
Q3 		$9.85M Buy
+51,700
New +$9.5M 0.04% 466

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

PEAK6 Investments's AGN Position: Q2 2020 in Review

PEAK6 Investments sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 44,463 shares — an estimated $7.87M sold.

PEAK6 Investments first reported a position in AGN in Q4 2018 and held it in 5 quarters. The position peaked at $17.9M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • PEAK6 Investments reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • PEAK6 Investments sold 44,463 Allergan plc shares in Q2 2020, an estimated $7.87M.
  • PEAK6 Investments first reported a position in Allergan plc in Q4 2018 and held it in 5 quarters.
  • PEAK6 Investments's Allergan plc position peaked at $17.9M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on PEAK6 Investments's 13F filing for Q2 2020, filed 14 Aug 2020.